Date: 2014-11-06 23:49:33

Organochlorides

Organofluorides

Sulfonamides

Vemurafenib

BRAF

Pharmaceutical Benefits Scheme

Melbourne Sports and Aquatic Centre

Mutation testing

Ipilimumab

Medicine

Health

Melanoma

Public Summary Document Application No. 1172 – BRAF genetic testing in patients with melanoma for access to proposed PBS-funded vemurafenib Sponsor/Applicant/s: Roche Diagnostic Australia Pty Limited and

Document is deleted from original location.
Use the Download Button below to download from the Web Archive.

File Size: 70,22 KB